. Author manuscript; available in PMC: 2014 May 22.

Published in final edited form as: Calif Agric (Berkeley). 2011 July-September;65(3):106–111. doi: 10.3733/ca.v065n03p106

TABLE 3.

Differences in serum oxylipin categories between patients whose kidney function was either nonimproved or improved^*

Oxylipin^†	Nonimproved		Improved		P^‡
Oxylipin^†	Mean	SE	Mean	SE	P^‡
	——— nmol/l ———

5-LOX^§	54,790	6,346	39,330	5,752	0.06

COX^¶	358.0	43.99	243.5	33.18	0.02

Data are means and SE for oxylipin categories significantly different between patients whose kidney function was either nonimproved (> −25% change in UP/C ratio) improved (≤ −25% change in UP/C ratio) from baseline to 2 Years.

^†

LOX = lipoxygenase; COX = cyclooxygenase.

^‡

Student’s t-test comparing two groups.

^§

Total 5-LOX values measured at baseline (presupplmentation).

^¶

Total COX values measured postsupplmentation.